|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
13,677,000 |
Market
Cap: |
13.68(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.001 - $0.001 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kazado Daniel |
Director |
|
2015-07-15 |
4 |
OE |
$1.51 |
$22,131 |
D/D |
14,656 |
23,048 |
|
- |
|
Teper Daniel Gedeon |
CEO |
|
2015-07-08 |
4 |
OE |
$1.51 |
$13,447 |
D/D |
8,905 |
4,453,636 |
|
- |
|
Sidransky David |
Director |
|
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,409 |
21,699 |
|
- |
|
Durrant Cameron |
Director |
|
2014-11-26 |
4 |
B |
$2.50 |
$10,000 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
Stancic Ana |
Director |
|
2014-11-26 |
4 |
B |
$2.50 |
$20,000 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
Kazado Daniel |
Director |
|
2014-11-26 |
4 |
B |
$2.50 |
$20,000 |
D/D |
8,000 |
8,392 |
2.39 |
- |
|
Berdugo Gad |
Director |
|
2014-11-26 |
4 |
B |
$2.50 |
$20,000 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
Sidransky David |
Director |
|
2014-11-26 |
4 |
B |
$2.50 |
$26,000 |
D/D |
10,400 |
18,290 |
2.39 |
- |
|
Sidransky David |
Director |
|
2013-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,951 |
5,951 |
|
- |
|
Teper Daniel Gedeon |
Chairman & CEO |
|
2013-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,260,556 |
4,260,556 |
|
- |
|
Brownlie Keith L |
Director |
|
2013-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
360,000 |
|
- |
|
Dunton Alan W |
Director |
|
2013-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
525,000 |
705,000 |
|
- |
|
Savage Robert G |
Director |
|
2013-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
475,300 |
|
- |
|
Allard Stephane |
Chief Medical Officer |
|
2012-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
350,000 |
414,180 |
|
- |
|
Cook Robert W |
Interim Chief Exec. Officer |
|
2012-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
450,000 |
504,957 |
|
- |
|
Dunton Alan W |
Director |
|
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
|
- |
|
Savage Robert G |
Director |
|
2007-12-13 |
4 |
B |
$1.35 |
$41,338 |
I/I |
30,000 |
70,100 |
2.1 |
- |
|
Talley John V |
President, CEO & Director |
|
2007-12-13 |
4 |
B |
$1.40 |
$21,000 |
D/D |
15,000 |
117,146 |
2.81 |
- |
|
Cook Robert W |
CFO-SVP, Finance & Admin. |
|
2007-12-13 |
4 |
B |
$1.35 |
$6,750 |
D/D |
5,000 |
15,000 |
2.74 |
- |
|
Wiedemann Oliver |
Managing Director-See Remarks |
|
2007-12-12 |
4 |
B |
$1.40 |
$7,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
Bhagwat Dileep |
SVP-Pharmaceutical Development |
|
2007-12-12 |
4 |
B |
$1.42 |
$14,275 |
D/D |
10,000 |
12,500 |
2.74 |
- |
|
Allard Stephane |
Chief Medical Officer |
|
2007-12-12 |
4 |
B |
$1.41 |
$14,100 |
I/I |
10,000 |
45,600 |
1.99 |
- |
|
Allard Stephane |
Chief Medical Officer |
|
2007-12-12 |
4 |
B |
$1.42 |
$2,556 |
D/D |
1,800 |
35,600 |
2.66 |
- |
|
Allard Stephane |
Chief Medical Officer |
|
2007-12-11 |
4 |
B |
$1.43 |
$47,476 |
D/D |
33,200 |
33,800 |
2.74 |
- |
|
Allard Stephane |
Chief Medical Officer |
|
2007-09-13 |
4 |
B |
$1.62 |
$972 |
D/D |
600 |
600 |
2.66 |
- |
|
72 Records found
|
|
Page 2 of 3 |
|
|